company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,641000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,641000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,480000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-997000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,136000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,136000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1412000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,312000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1516000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1516000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1357000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-346000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1768000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1768000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-88000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5970000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5970000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,577000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6275000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-447000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,435000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,435000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-193000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,42000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-86000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-86000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-724000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-513000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,521000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-651000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-651000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,29000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-301000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,610000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,610000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,527000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,655000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-997000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,795000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,795000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-212000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-180000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,43000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,331000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,104000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,104000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-623000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-188000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-825000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-825000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,7000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11730000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11730000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,528000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13583000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1522000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,859000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,859000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-267000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1870000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,315000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1912000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1912000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2353000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-152000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2506000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2506000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,18000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,283000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,795000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,106000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1134000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1134000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,507000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,684000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-829000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1496000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1496000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-56000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,824000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,434000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1039000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1039000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6509000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-22000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4440000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2091000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2091000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,11000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,455000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,479000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,733000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-884000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,162000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,162000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,525000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,406000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,406000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-5000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-69000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,443000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-197000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-197000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,474000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,610000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-466000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,421000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,421000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,447000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,347000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,347000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-704000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-705000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-705000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-49000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3243000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3243000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3844000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-616000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,367000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,367000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,340000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,74000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,74000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-499000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-499000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-499000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-93000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,815000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,420000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-97000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-97000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,443000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,521000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-755000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,112000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,112000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,386000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,272000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,272000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-137000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-52000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-189000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-189000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,191000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-671000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-671000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,450000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,646000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-652000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-227000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-227000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,419000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,429000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,429000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,25000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,192000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-308000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-308000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,244000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,325000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,325000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,362000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,224000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,224000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1557000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,96000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1461000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1461000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-12000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-924000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,416000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,468000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-422000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,538000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,538000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,174000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,378000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,430000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,430000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2228000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1987000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-241000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-241000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,7000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,734000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,840000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,552000000.0
